Impact of traditional rice consumption over normal rice in reducing obesity among children aged 10-14 years attending paediatric endocrine clinic at Lady Ridgeway Hospital for children, Sri Lanka: A randomized controlled trial

Efficacy of consumption of traditional rice compared to normal rice in reducing obesity among children aged 10-14 years attending paediatric endocrine clinic at Lady Ridgeway Hospital for children, Sri Lanka: A randomized controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

SLCTR

Registry ID

SLCTR/2025/022

Enrollment

Unknown

Registered

2025-06-05

Start date

2025-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood obesity

Interventions

1. Study Setting -The study will be conducted at the Department of biochemistry, Faculty of medical sciences, University of Sri Jayewardenepura and Lady Ridgeway Hospital for Children (LRH), Colombo 0

Eligibility

Inclusion criteria

Inclusion criteria: - Children of both sexes - Children between 10 to 14 years of age - Children with a body mass index (BMI) of over the 95th centile for age and sex (BMI between +2 SD t+3 SD, WHO normative data) - Normotensive blood pressure less than 95th centile for height, sex, and age

Exclusion criteria

Exclusion criteria: - Children with extreme obesity (BMI more than +3 SD WHO normative data) - Children with Pre- diabetes or diabetes (HbA1C ?5.7%) - Children with Total cholesterol ?200 mg/ dL, low-density lipoprotein ?130 mg/dL - Children with Hypothyroidism - Children with any other known endocrine disorders. - Children with chronic diseases

Design outcomes

Primary

Measure	Time frame
Absolute reduction of BMI from baseline Absolute change: BMI Week 26 – BMI Week 0 [Post-Intervention (Week 26)] Relative change in BMI Middle of intervention: (BMI Week 13 – BMIWeek0) ÷ BMI Week0 × 100% Post-Intervention: (BMI Week 26 – BMIWeek0) ÷ BMI Week0 × 100% [Middle of the intervention (Week 13) Post-Intervention (Week 26)]	—

Secondary

Measure	Time frame
Anthropometric parameters, Measurement variable -Mid-upper arm circumference, Waist circumference, Body fat Analysis metric - reduction from baseline Method of aggregation- mean(SD) [Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26)] Biochemical parameters Measurement variable -Fasting blood sugar (FBS), HbA1c, Insulin, Leptin levels, Lipid profile, Liver function test [Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26)]	—

Measure

Time frame

Anthropometric parameters, Measurement variable -Mid-upper arm circumference, Waist circumference, Body fat Analysis metric - reduction from baseline Method of aggregation- mean(SD) [Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26)] Biochemical parameters Measurement variable -Fasting blood sugar (FBS), HbA1c, Insulin, Leptin levels, Lipid profile, Liver function test [Baseline (Week 0) Middle of the intervention (Week 13) Post-Intervention (Week 26)]

—

Countries

Sri Lanka

Contacts

Public ContactProf. Sagarika Ekanayake

Senior Professor

sagarikae@sjp.ac.lk

Outcome results

None listed

Source: SLCTR (via WHO ICTRP) · Data processed: Aug 10, 2026